Company | SAPL | Symbol |
Company Name | Sanofi-Aventis Pakistan Limited | Company Name |
Sector | Pharma and Bio Tech | Sector |
Avg EPS | Rs 21.29 | Average of past year end EPS's |
Sector Average | Rs 19.88 | Sector average of the above |
Avg EPS FV | Rs 158.40 | Fair Value (DCF) based on average of past year end EPS's |
EPS | Rs 41.05 | Last four quarters EPS |
Sector Average | Rs 27.73 | Sector average of the above |
EPS FV | Rs 305.43 | Fair Value (DCF) based on last four quarters EPS |
Current Price | Rs 417.99 | Last closing stock price |
Updated | November 2013 | Data Month/Year |
Div | Rs 12.50 | Total dividend paid during last four quarters |
Sector Average | Rs 13.17 | Sector average of the above |
Div FV | Rs 93.01 | Fair value (DD) based on total dividend paid during last four quarters |
Avg Div | Rs 6.15 | Average of yearly dividends paid (including currently paid ones) |
Sector Average | Rs 10.60 | Sector average of the above |
Avg Div FV | Rs 45.76 | Fair value (DD) based on Average of yearly dividends paid (including current) |
Avg | Rs -28.04 | Fair value (averaged of other fair values) |
Upside | -106.71% | Upside potential (in percentage) based on the above Average. |
Div Yield | 2.99% | Dividend yield |
Sector Average | 3.04% | Sector average of the above |
Book Value | Rs 207.37 | Book Value |
Sector Average | Rs 189.93 | Sector average of the above |
FV FCF/S | Rs -848.59 | Fair Value based on free cash flow per share |
Outstanding Shares | 9,644,800 | Number of Outstanding Shares |
Current Assets | Rs 4,272.00 | Currency in Millions of Pakistan Rupees |
Total Liabilities | Rs 4,043.00 | Currency in Millions of Pakistan Rupees |
NCAV/S | Rs 23.74 | Net Current Asset Value / Share |
NNWC/S | Rs -209.47 | Net Net Working Capital / Share |
Total Assets | Rs 6,043.00 | Currency in Millions of Pakistan Rupees |
Quarter | June 2013 | Financial Report Quarter |
CfO | Rs -609.00 | Cash from Operations (Millions of Rs) |
FCF/S | Rs -114.05 | Free Cash Flow per Share |
FCF/S Sector Avg | 10.94 | Sector Average FCF/S |
P/FCF | -3.66 | Price over free cash flow |
P/FCF Sector Avg | 21.31 | Sector Average P/FCF |
P/E | 10.18 | Price over earnings ratio |
P/E Sector Avg | 0.14 | Sector Average P/E |
P/B | 2.02 | Price over book value ratio |
P/B Sector Avg | 3.14 | Sector Average P/B |
PR | 30.45 | Payout Ratio (in %) |
PR Sector Avg | 2.38 | Sector average Payout Ratio (in %) |
D/E Ratio | 202.15 | Debt / Equity ratio (%) |
Sector D/E Ratio | 85.63 | Sector Debt / Equity ratio (%) |
Price Performance | ||
Last Trade Date | 13/11/2013 | |
Last Trade Price | Rs 417.99 | |
3 Months Avg | Rs 501.22 | |
6 Months Avg | Rs 439.19 | |
9 Months Avg | Rs 366.74 | |
12 Months Avg | Rs 317.36 | |
Score | -10 | cumulative +ve's, -ve's from above all |
Buy Scale | 1 | Range -5 to +5 (based on 5 different complex analysis) |
Saturday, November 16, 2013
SAPL- Sanofi-Aventis Pakistan Limited - Company Analysis - 16-11-2013
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment